Tuesday Could Be a Winning Market Day Despite Earnings Headwinds From These 2 StocksThe Motley Fool • 10/19/21
Johnson & Johnson Shares Gain After Q3 Earnings Beat Wall Street; Raises FY21 GuidanceBenzinga • 10/19/21
Johnson & Johnson May Not Have to Wait Long for Its Next Blockbuster VaccineThe Motley Fool • 10/19/21
J&J beats profit estimates for latest quarter as sales fall short and company raises full-year guidanceMarket Watch • 10/19/21
Why Johnson & Johnson Will Be a Bigger Winner With Boosters Than Pfizer and ModernaThe Motley Fool • 10/19/21
J&J boosters are on the horizon for everyone who got that shot - regardless of age, job, or healthBusiness Insider • 10/15/21
Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory CommitteePRNewsWire • 10/15/21